Global Humira Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a readjusted size of US$ 8891.4 million by 2030 with a CAGR of -8.6% during review period.
The research report highlights the growth potential of the global Humira market. Humira are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Humira. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Humira market.
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
Key Features:
The report on Humira market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Humira market. It may include historical data, market segmentation by Type (e.g., Humira Syringe, Humira Pen), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Humira market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Humira market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Humira industry. This include advancements in Humira technology, Humira new entrants, Humira new investment, and other innovations that are shaping the future of Humira.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Humira market. It includes factors influencing customer ' purchasing decisions, preferences for Humira product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Humira market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Humira market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Humira market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Humira industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Humira market.
Market Segmentation:
Humira market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Humira market?
What factors are driving Humira market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Humira market opportunities vary by end market size?
How does Humira break out type, application?
According to our LPI (LP Information) latest study, the global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a readjusted size of US$ 8891.4 million by 2030 with a CAGR of -8.6% during review period.
The research report highlights the growth potential of the global Humira market. Humira are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Humira. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Humira market.
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
Key Features:
The report on Humira market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Humira market. It may include historical data, market segmentation by Type (e.g., Humira Syringe, Humira Pen), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Humira market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Humira market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Humira industry. This include advancements in Humira technology, Humira new entrants, Humira new investment, and other innovations that are shaping the future of Humira.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Humira market. It includes factors influencing customer ' purchasing decisions, preferences for Humira product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Humira market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Humira market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Humira market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Humira industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Humira market.
Market Segmentation:
Humira market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Humira Syringe
- Humira Pen
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Crohn’s Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Eisai
- Cadila Healthcare
- Amgen
- Boehringer Ingelheim
- Samsung Bioepis
- Biocon
- Fresenius Kabi
- Celltrion
- Coherus
- Sandoz
- Torrent Pharmaceuticals
What is the 10-year outlook for the global Humira market?
What factors are driving Humira market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Humira market opportunities vary by end market size?
How does Humira break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Humira Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Humira by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Humira by Country/Region, 2019, 2023 & 2030
2.2 Humira Segment by Type
2.2.1 Humira Syringe
2.2.2 Humira Pen
2.3 Humira Sales by Type
2.3.1 Global Humira Sales Market Share by Type (2019-2024)
2.3.2 Global Humira Revenue and Market Share by Type (2019-2024)
2.3.3 Global Humira Sale Price by Type (2019-2024)
2.4 Humira Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Rheumatoid Arthritis
2.4.3 Crohn’s Disease
2.4.4 Others
2.5 Humira Sales by Application
2.5.1 Global Humira Sale Market Share by Application (2019-2024)
2.5.2 Global Humira Revenue and Market Share by Application (2019-2024)
2.5.3 Global Humira Sale Price by Application (2019-2024)
3 GLOBAL HUMIRA BY COMPANY
3.1 Global Humira Breakdown Data by Company
3.1.1 Global Humira Annual Sales by Company (2019-2024)
3.1.2 Global Humira Sales Market Share by Company (2019-2024)
3.2 Global Humira Annual Revenue by Company (2019-2024)
3.2.1 Global Humira Revenue by Company (2019-2024)
3.2.2 Global Humira Revenue Market Share by Company (2019-2024)
3.3 Global Humira Sale Price by Company
3.4 Key Manufacturers Humira Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Humira Product Location Distribution
3.4.2 Players Humira Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMIRA BY GEOGRAPHIC REGION
4.1 World Historic Humira Market Size by Geographic Region (2019-2024)
4.1.1 Global Humira Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Humira Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Humira Market Size by Country/Region (2019-2024)
4.2.1 Global Humira Annual Sales by Country/Region (2019-2024)
4.2.2 Global Humira Annual Revenue by Country/Region (2019-2024)
4.3 Americas Humira Sales Growth
4.4 APAC Humira Sales Growth
4.5 Europe Humira Sales Growth
4.6 Middle East & Africa Humira Sales Growth
5 AMERICAS
5.1 Americas Humira Sales by Country
5.1.1 Americas Humira Sales by Country (2019-2024)
5.1.2 Americas Humira Revenue by Country (2019-2024)
5.2 Americas Humira Sales by Type
5.3 Americas Humira Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Humira Sales by Region
6.1.1 APAC Humira Sales by Region (2019-2024)
6.1.2 APAC Humira Revenue by Region (2019-2024)
6.2 APAC Humira Sales by Type
6.3 APAC Humira Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Humira by Country
7.1.1 Europe Humira Sales by Country (2019-2024)
7.1.2 Europe Humira Revenue by Country (2019-2024)
7.2 Europe Humira Sales by Type
7.3 Europe Humira Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Humira by Country
8.1.1 Middle East & Africa Humira Sales by Country (2019-2024)
8.1.2 Middle East & Africa Humira Revenue by Country (2019-2024)
8.2 Middle East & Africa Humira Sales by Type
8.3 Middle East & Africa Humira Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Humira
10.3 Manufacturing Process Analysis of Humira
10.4 Industry Chain Structure of Humira
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Humira Distributors
11.3 Humira Customer
12 WORLD FORECAST REVIEW FOR HUMIRA BY GEOGRAPHIC REGION
12.1 Global Humira Market Size Forecast by Region
12.1.1 Global Humira Forecast by Region (2025-2030)
12.1.2 Global Humira Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Humira Forecast by Type
12.7 Global Humira Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Humira Product Portfolios and Specifications
13.1.3 AbbVie Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Eisai
13.2.1 Eisai Company Information
13.2.2 Eisai Humira Product Portfolios and Specifications
13.2.3 Eisai Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Eisai Main Business Overview
13.2.5 Eisai Latest Developments
13.3 Cadila Healthcare
13.3.1 Cadila Healthcare Company Information
13.3.2 Cadila Healthcare Humira Product Portfolios and Specifications
13.3.3 Cadila Healthcare Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Cadila Healthcare Main Business Overview
13.3.5 Cadila Healthcare Latest Developments
13.4 Amgen
13.4.1 Amgen Company Information
13.4.2 Amgen Humira Product Portfolios and Specifications
13.4.3 Amgen Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Amgen Main Business Overview
13.4.5 Amgen Latest Developments
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Information
13.5.2 Boehringer Ingelheim Humira Product Portfolios and Specifications
13.5.3 Boehringer Ingelheim Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Boehringer Ingelheim Main Business Overview
13.5.5 Boehringer Ingelheim Latest Developments
13.6 Samsung Bioepis
13.6.1 Samsung Bioepis Company Information
13.6.2 Samsung Bioepis Humira Product Portfolios and Specifications
13.6.3 Samsung Bioepis Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Samsung Bioepis Main Business Overview
13.6.5 Samsung Bioepis Latest Developments
13.7 Biocon
13.7.1 Biocon Company Information
13.7.2 Biocon Humira Product Portfolios and Specifications
13.7.3 Biocon Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Biocon Main Business Overview
13.7.5 Biocon Latest Developments
13.8 Fresenius Kabi
13.8.1 Fresenius Kabi Company Information
13.8.2 Fresenius Kabi Humira Product Portfolios and Specifications
13.8.3 Fresenius Kabi Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Fresenius Kabi Main Business Overview
13.8.5 Fresenius Kabi Latest Developments
13.9 Celltrion
13.9.1 Celltrion Company Information
13.9.2 Celltrion Humira Product Portfolios and Specifications
13.9.3 Celltrion Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Celltrion Main Business Overview
13.9.5 Celltrion Latest Developments
13.10 Coherus
13.10.1 Coherus Company Information
13.10.2 Coherus Humira Product Portfolios and Specifications
13.10.3 Coherus Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Coherus Main Business Overview
13.10.5 Coherus Latest Developments
13.11 Sandoz
13.11.1 Sandoz Company Information
13.11.2 Sandoz Humira Product Portfolios and Specifications
13.11.3 Sandoz Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Sandoz Main Business Overview
13.11.5 Sandoz Latest Developments
13.12 Torrent Pharmaceuticals
13.12.1 Torrent Pharmaceuticals Company Information
13.12.2 Torrent Pharmaceuticals Humira Product Portfolios and Specifications
13.12.3 Torrent Pharmaceuticals Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Torrent Pharmaceuticals Main Business Overview
13.12.5 Torrent Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Humira Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Humira by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Humira by Country/Region, 2019, 2023 & 2030
2.2 Humira Segment by Type
2.2.1 Humira Syringe
2.2.2 Humira Pen
2.3 Humira Sales by Type
2.3.1 Global Humira Sales Market Share by Type (2019-2024)
2.3.2 Global Humira Revenue and Market Share by Type (2019-2024)
2.3.3 Global Humira Sale Price by Type (2019-2024)
2.4 Humira Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Rheumatoid Arthritis
2.4.3 Crohn’s Disease
2.4.4 Others
2.5 Humira Sales by Application
2.5.1 Global Humira Sale Market Share by Application (2019-2024)
2.5.2 Global Humira Revenue and Market Share by Application (2019-2024)
2.5.3 Global Humira Sale Price by Application (2019-2024)
3 GLOBAL HUMIRA BY COMPANY
3.1 Global Humira Breakdown Data by Company
3.1.1 Global Humira Annual Sales by Company (2019-2024)
3.1.2 Global Humira Sales Market Share by Company (2019-2024)
3.2 Global Humira Annual Revenue by Company (2019-2024)
3.2.1 Global Humira Revenue by Company (2019-2024)
3.2.2 Global Humira Revenue Market Share by Company (2019-2024)
3.3 Global Humira Sale Price by Company
3.4 Key Manufacturers Humira Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Humira Product Location Distribution
3.4.2 Players Humira Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMIRA BY GEOGRAPHIC REGION
4.1 World Historic Humira Market Size by Geographic Region (2019-2024)
4.1.1 Global Humira Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Humira Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Humira Market Size by Country/Region (2019-2024)
4.2.1 Global Humira Annual Sales by Country/Region (2019-2024)
4.2.2 Global Humira Annual Revenue by Country/Region (2019-2024)
4.3 Americas Humira Sales Growth
4.4 APAC Humira Sales Growth
4.5 Europe Humira Sales Growth
4.6 Middle East & Africa Humira Sales Growth
5 AMERICAS
5.1 Americas Humira Sales by Country
5.1.1 Americas Humira Sales by Country (2019-2024)
5.1.2 Americas Humira Revenue by Country (2019-2024)
5.2 Americas Humira Sales by Type
5.3 Americas Humira Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Humira Sales by Region
6.1.1 APAC Humira Sales by Region (2019-2024)
6.1.2 APAC Humira Revenue by Region (2019-2024)
6.2 APAC Humira Sales by Type
6.3 APAC Humira Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Humira by Country
7.1.1 Europe Humira Sales by Country (2019-2024)
7.1.2 Europe Humira Revenue by Country (2019-2024)
7.2 Europe Humira Sales by Type
7.3 Europe Humira Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Humira by Country
8.1.1 Middle East & Africa Humira Sales by Country (2019-2024)
8.1.2 Middle East & Africa Humira Revenue by Country (2019-2024)
8.2 Middle East & Africa Humira Sales by Type
8.3 Middle East & Africa Humira Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Humira
10.3 Manufacturing Process Analysis of Humira
10.4 Industry Chain Structure of Humira
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Humira Distributors
11.3 Humira Customer
12 WORLD FORECAST REVIEW FOR HUMIRA BY GEOGRAPHIC REGION
12.1 Global Humira Market Size Forecast by Region
12.1.1 Global Humira Forecast by Region (2025-2030)
12.1.2 Global Humira Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Humira Forecast by Type
12.7 Global Humira Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Humira Product Portfolios and Specifications
13.1.3 AbbVie Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Eisai
13.2.1 Eisai Company Information
13.2.2 Eisai Humira Product Portfolios and Specifications
13.2.3 Eisai Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Eisai Main Business Overview
13.2.5 Eisai Latest Developments
13.3 Cadila Healthcare
13.3.1 Cadila Healthcare Company Information
13.3.2 Cadila Healthcare Humira Product Portfolios and Specifications
13.3.3 Cadila Healthcare Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Cadila Healthcare Main Business Overview
13.3.5 Cadila Healthcare Latest Developments
13.4 Amgen
13.4.1 Amgen Company Information
13.4.2 Amgen Humira Product Portfolios and Specifications
13.4.3 Amgen Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Amgen Main Business Overview
13.4.5 Amgen Latest Developments
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Information
13.5.2 Boehringer Ingelheim Humira Product Portfolios and Specifications
13.5.3 Boehringer Ingelheim Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Boehringer Ingelheim Main Business Overview
13.5.5 Boehringer Ingelheim Latest Developments
13.6 Samsung Bioepis
13.6.1 Samsung Bioepis Company Information
13.6.2 Samsung Bioepis Humira Product Portfolios and Specifications
13.6.3 Samsung Bioepis Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Samsung Bioepis Main Business Overview
13.6.5 Samsung Bioepis Latest Developments
13.7 Biocon
13.7.1 Biocon Company Information
13.7.2 Biocon Humira Product Portfolios and Specifications
13.7.3 Biocon Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Biocon Main Business Overview
13.7.5 Biocon Latest Developments
13.8 Fresenius Kabi
13.8.1 Fresenius Kabi Company Information
13.8.2 Fresenius Kabi Humira Product Portfolios and Specifications
13.8.3 Fresenius Kabi Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Fresenius Kabi Main Business Overview
13.8.5 Fresenius Kabi Latest Developments
13.9 Celltrion
13.9.1 Celltrion Company Information
13.9.2 Celltrion Humira Product Portfolios and Specifications
13.9.3 Celltrion Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Celltrion Main Business Overview
13.9.5 Celltrion Latest Developments
13.10 Coherus
13.10.1 Coherus Company Information
13.10.2 Coherus Humira Product Portfolios and Specifications
13.10.3 Coherus Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Coherus Main Business Overview
13.10.5 Coherus Latest Developments
13.11 Sandoz
13.11.1 Sandoz Company Information
13.11.2 Sandoz Humira Product Portfolios and Specifications
13.11.3 Sandoz Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Sandoz Main Business Overview
13.11.5 Sandoz Latest Developments
13.12 Torrent Pharmaceuticals
13.12.1 Torrent Pharmaceuticals Company Information
13.12.2 Torrent Pharmaceuticals Humira Product Portfolios and Specifications
13.12.3 Torrent Pharmaceuticals Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Torrent Pharmaceuticals Main Business Overview
13.12.5 Torrent Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Humira Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Humira Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Humira Syringe
Table 4. Major Players of Humira Pen
Table 5. Global Humira Sales by Type (2019-2024) & (K Units)
Table 6. Global Humira Sales Market Share by Type (2019-2024)
Table 7. Global Humira Revenue by Type (2019-2024) & ($ million)
Table 8. Global Humira Revenue Market Share by Type (2019-2024)
Table 9. Global Humira Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Humira Sales by Application (2019-2024) & (K Units)
Table 11. Global Humira Sales Market Share by Application (2019-2024)
Table 12. Global Humira Revenue by Application (2019-2024)
Table 13. Global Humira Revenue Market Share by Application (2019-2024)
Table 14. Global Humira Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Humira Sales by Company (2019-2024) & (K Units)
Table 16. Global Humira Sales Market Share by Company (2019-2024)
Table 17. Global Humira Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Humira Revenue Market Share by Company (2019-2024)
Table 19. Global Humira Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Humira Producing Area Distribution and Sales Area
Table 21. Players Humira Products Offered
Table 22. Humira Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Humira Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Humira Sales Market Share Geographic Region (2019-2024)
Table 27. Global Humira Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Humira Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Humira Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Humira Sales Market Share by Country/Region (2019-2024)
Table 31. Global Humira Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Humira Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Humira Sales by Country (2019-2024) & (K Units)
Table 34. Americas Humira Sales Market Share by Country (2019-2024)
Table 35. Americas Humira Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Humira Revenue Market Share by Country (2019-2024)
Table 37. Americas Humira Sales by Type (2019-2024) & (K Units)
Table 38. Americas Humira Sales by Application (2019-2024) & (K Units)
Table 39. APAC Humira Sales by Region (2019-2024) & (K Units)
Table 40. APAC Humira Sales Market Share by Region (2019-2024)
Table 41. APAC Humira Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Humira Revenue Market Share by Region (2019-2024)
Table 43. APAC Humira Sales by Type (2019-2024) & (K Units)
Table 44. APAC Humira Sales by Application (2019-2024) & (K Units)
Table 45. Europe Humira Sales by Country (2019-2024) & (K Units)
Table 46. Europe Humira Sales Market Share by Country (2019-2024)
Table 47. Europe Humira Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Humira Revenue Market Share by Country (2019-2024)
Table 49. Europe Humira Sales by Type (2019-2024) & (K Units)
Table 50. Europe Humira Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Humira Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Humira Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Humira Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Humira Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Humira Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Humira Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Humira
Table 58. Key Market Challenges & Risks of Humira
Table 59. Key Industry Trends of Humira
Table 60. Humira Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Humira Distributors List
Table 63. Humira Customer List
Table 64. Global Humira Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Humira Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Humira Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Humira Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Humira Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Humira Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Humira Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Humira Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Humira Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Humira Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Humira Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Humira Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Humira Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Humira Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. AbbVie Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 79. AbbVie Humira Product Portfolios and Specifications
Table 80. AbbVie Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. AbbVie Main Business
Table 82. AbbVie Latest Developments
Table 83. Eisai Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 84. Eisai Humira Product Portfolios and Specifications
Table 85. Eisai Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Eisai Main Business
Table 87. Eisai Latest Developments
Table 88. Cadila Healthcare Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 89. Cadila Healthcare Humira Product Portfolios and Specifications
Table 90. Cadila Healthcare Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Cadila Healthcare Main Business
Table 92. Cadila Healthcare Latest Developments
Table 93. Amgen Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 94. Amgen Humira Product Portfolios and Specifications
Table 95. Amgen Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Amgen Main Business
Table 97. Amgen Latest Developments
Table 98. Boehringer Ingelheim Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 99. Boehringer Ingelheim Humira Product Portfolios and Specifications
Table 100. Boehringer Ingelheim Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Boehringer Ingelheim Main Business
Table 102. Boehringer Ingelheim Latest Developments
Table 103. Samsung Bioepis Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 104. Samsung Bioepis Humira Product Portfolios and Specifications
Table 105. Samsung Bioepis Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Samsung Bioepis Main Business
Table 107. Samsung Bioepis Latest Developments
Table 108. Biocon Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 109. Biocon Humira Product Portfolios and Specifications
Table 110. Biocon Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Biocon Main Business
Table 112. Biocon Latest Developments
Table 113. Fresenius Kabi Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 114. Fresenius Kabi Humira Product Portfolios and Specifications
Table 115. Fresenius Kabi Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Fresenius Kabi Main Business
Table 117. Fresenius Kabi Latest Developments
Table 118. Celltrion Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 119. Celltrion Humira Product Portfolios and Specifications
Table 120. Celltrion Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Celltrion Main Business
Table 122. Celltrion Latest Developments
Table 123. Coherus Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 124. Coherus Humira Product Portfolios and Specifications
Table 125. Coherus Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Coherus Main Business
Table 127. Coherus Latest Developments
Table 128. Sandoz Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 129. Sandoz Humira Product Portfolios and Specifications
Table 130. Sandoz Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. Sandoz Main Business
Table 132. Sandoz Latest Developments
Table 133. Torrent Pharmaceuticals Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 134. Torrent Pharmaceuticals Humira Product Portfolios and Specifications
Table 135. Torrent Pharmaceuticals Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. Torrent Pharmaceuticals Main Business
Table 137. Torrent Pharmaceuticals Latest Developments
Table 1. Humira Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Humira Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Humira Syringe
Table 4. Major Players of Humira Pen
Table 5. Global Humira Sales by Type (2019-2024) & (K Units)
Table 6. Global Humira Sales Market Share by Type (2019-2024)
Table 7. Global Humira Revenue by Type (2019-2024) & ($ million)
Table 8. Global Humira Revenue Market Share by Type (2019-2024)
Table 9. Global Humira Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Humira Sales by Application (2019-2024) & (K Units)
Table 11. Global Humira Sales Market Share by Application (2019-2024)
Table 12. Global Humira Revenue by Application (2019-2024)
Table 13. Global Humira Revenue Market Share by Application (2019-2024)
Table 14. Global Humira Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Humira Sales by Company (2019-2024) & (K Units)
Table 16. Global Humira Sales Market Share by Company (2019-2024)
Table 17. Global Humira Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Humira Revenue Market Share by Company (2019-2024)
Table 19. Global Humira Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Humira Producing Area Distribution and Sales Area
Table 21. Players Humira Products Offered
Table 22. Humira Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Humira Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Humira Sales Market Share Geographic Region (2019-2024)
Table 27. Global Humira Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Humira Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Humira Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Humira Sales Market Share by Country/Region (2019-2024)
Table 31. Global Humira Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Humira Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Humira Sales by Country (2019-2024) & (K Units)
Table 34. Americas Humira Sales Market Share by Country (2019-2024)
Table 35. Americas Humira Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Humira Revenue Market Share by Country (2019-2024)
Table 37. Americas Humira Sales by Type (2019-2024) & (K Units)
Table 38. Americas Humira Sales by Application (2019-2024) & (K Units)
Table 39. APAC Humira Sales by Region (2019-2024) & (K Units)
Table 40. APAC Humira Sales Market Share by Region (2019-2024)
Table 41. APAC Humira Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Humira Revenue Market Share by Region (2019-2024)
Table 43. APAC Humira Sales by Type (2019-2024) & (K Units)
Table 44. APAC Humira Sales by Application (2019-2024) & (K Units)
Table 45. Europe Humira Sales by Country (2019-2024) & (K Units)
Table 46. Europe Humira Sales Market Share by Country (2019-2024)
Table 47. Europe Humira Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Humira Revenue Market Share by Country (2019-2024)
Table 49. Europe Humira Sales by Type (2019-2024) & (K Units)
Table 50. Europe Humira Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Humira Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Humira Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Humira Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Humira Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Humira Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Humira Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Humira
Table 58. Key Market Challenges & Risks of Humira
Table 59. Key Industry Trends of Humira
Table 60. Humira Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Humira Distributors List
Table 63. Humira Customer List
Table 64. Global Humira Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Humira Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Humira Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Humira Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Humira Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Humira Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Humira Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Humira Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Humira Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Humira Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Humira Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Humira Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Humira Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Humira Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. AbbVie Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 79. AbbVie Humira Product Portfolios and Specifications
Table 80. AbbVie Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. AbbVie Main Business
Table 82. AbbVie Latest Developments
Table 83. Eisai Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 84. Eisai Humira Product Portfolios and Specifications
Table 85. Eisai Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Eisai Main Business
Table 87. Eisai Latest Developments
Table 88. Cadila Healthcare Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 89. Cadila Healthcare Humira Product Portfolios and Specifications
Table 90. Cadila Healthcare Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Cadila Healthcare Main Business
Table 92. Cadila Healthcare Latest Developments
Table 93. Amgen Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 94. Amgen Humira Product Portfolios and Specifications
Table 95. Amgen Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Amgen Main Business
Table 97. Amgen Latest Developments
Table 98. Boehringer Ingelheim Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 99. Boehringer Ingelheim Humira Product Portfolios and Specifications
Table 100. Boehringer Ingelheim Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Boehringer Ingelheim Main Business
Table 102. Boehringer Ingelheim Latest Developments
Table 103. Samsung Bioepis Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 104. Samsung Bioepis Humira Product Portfolios and Specifications
Table 105. Samsung Bioepis Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Samsung Bioepis Main Business
Table 107. Samsung Bioepis Latest Developments
Table 108. Biocon Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 109. Biocon Humira Product Portfolios and Specifications
Table 110. Biocon Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Biocon Main Business
Table 112. Biocon Latest Developments
Table 113. Fresenius Kabi Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 114. Fresenius Kabi Humira Product Portfolios and Specifications
Table 115. Fresenius Kabi Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Fresenius Kabi Main Business
Table 117. Fresenius Kabi Latest Developments
Table 118. Celltrion Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 119. Celltrion Humira Product Portfolios and Specifications
Table 120. Celltrion Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Celltrion Main Business
Table 122. Celltrion Latest Developments
Table 123. Coherus Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 124. Coherus Humira Product Portfolios and Specifications
Table 125. Coherus Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Coherus Main Business
Table 127. Coherus Latest Developments
Table 128. Sandoz Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 129. Sandoz Humira Product Portfolios and Specifications
Table 130. Sandoz Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. Sandoz Main Business
Table 132. Sandoz Latest Developments
Table 133. Torrent Pharmaceuticals Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 134. Torrent Pharmaceuticals Humira Product Portfolios and Specifications
Table 135. Torrent Pharmaceuticals Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. Torrent Pharmaceuticals Main Business
Table 137. Torrent Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Humira
Figure 2. Humira Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Humira Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Humira Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Humira Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Humira Syringe
Figure 10. Product Picture of Humira Pen
Figure 11. Global Humira Sales Market Share by Type in 2023
Figure 12. Global Humira Revenue Market Share by Type (2019-2024)
Figure 13. Humira Consumed in Ankylosing Spondylitis
Figure 14. Global Humira Market: Ankylosing Spondylitis (2019-2024) & (K Units)
Figure 15. Humira Consumed in Rheumatoid Arthritis
Figure 16. Global Humira Market: Rheumatoid Arthritis (2019-2024) & (K Units)
Figure 17. Humira Consumed in Crohn’s Disease
Figure 18. Global Humira Market: Crohn’s Disease (2019-2024) & (K Units)
Figure 19. Humira Consumed in Others
Figure 20. Global Humira Market: Others (2019-2024) & (K Units)
Figure 21. Global Humira Sales Market Share by Application (2023)
Figure 22. Global Humira Revenue Market Share by Application in 2023
Figure 23. Humira Sales Market by Company in 2023 (K Units)
Figure 24. Global Humira Sales Market Share by Company in 2023
Figure 25. Humira Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Humira Revenue Market Share by Company in 2023
Figure 27. Global Humira Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Humira Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Humira Sales 2019-2024 (K Units)
Figure 30. Americas Humira Revenue 2019-2024 ($ Millions)
Figure 31. APAC Humira Sales 2019-2024 (K Units)
Figure 32. APAC Humira Revenue 2019-2024 ($ Millions)
Figure 33. Europe Humira Sales 2019-2024 (K Units)
Figure 34. Europe Humira Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Humira Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Humira Revenue 2019-2024 ($ Millions)
Figure 37. Americas Humira Sales Market Share by Country in 2023
Figure 38. Americas Humira Revenue Market Share by Country in 2023
Figure 39. Americas Humira Sales Market Share by Type (2019-2024)
Figure 40. Americas Humira Sales Market Share by Application (2019-2024)
Figure 41. United States Humira Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Humira Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Humira Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Humira Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Humira Sales Market Share by Region in 2023
Figure 46. APAC Humira Revenue Market Share by Regions in 2023
Figure 47. APAC Humira Sales Market Share by Type (2019-2024)
Figure 48. APAC Humira Sales Market Share by Application (2019-2024)
Figure 49. China Humira Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Humira Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Humira Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Humira Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Humira Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Humira Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Humira Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Humira Sales Market Share by Country in 2023
Figure 57. Europe Humira Revenue Market Share by Country in 2023
Figure 58. Europe Humira Sales Market Share by Type (2019-2024)
Figure 59. Europe Humira Sales Market Share by Application (2019-2024)
Figure 60. Germany Humira Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Humira Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Humira Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Humira Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Humira Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Humira Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Humira Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Humira Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Humira Sales Market Share by Application (2019-2024)
Figure 69. Egypt Humira Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Humira Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Humira Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Humira Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Humira Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Humira in 2023
Figure 75. Manufacturing Process Analysis of Humira
Figure 76. Industry Chain Structure of Humira
Figure 77. Channels of Distribution
Figure 78. Global Humira Sales Market Forecast by Region (2025-2030)
Figure 79. Global Humira Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Humira Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Humira Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Humira Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Humira Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Humira
Figure 2. Humira Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Humira Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Humira Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Humira Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Humira Syringe
Figure 10. Product Picture of Humira Pen
Figure 11. Global Humira Sales Market Share by Type in 2023
Figure 12. Global Humira Revenue Market Share by Type (2019-2024)
Figure 13. Humira Consumed in Ankylosing Spondylitis
Figure 14. Global Humira Market: Ankylosing Spondylitis (2019-2024) & (K Units)
Figure 15. Humira Consumed in Rheumatoid Arthritis
Figure 16. Global Humira Market: Rheumatoid Arthritis (2019-2024) & (K Units)
Figure 17. Humira Consumed in Crohn’s Disease
Figure 18. Global Humira Market: Crohn’s Disease (2019-2024) & (K Units)
Figure 19. Humira Consumed in Others
Figure 20. Global Humira Market: Others (2019-2024) & (K Units)
Figure 21. Global Humira Sales Market Share by Application (2023)
Figure 22. Global Humira Revenue Market Share by Application in 2023
Figure 23. Humira Sales Market by Company in 2023 (K Units)
Figure 24. Global Humira Sales Market Share by Company in 2023
Figure 25. Humira Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Humira Revenue Market Share by Company in 2023
Figure 27. Global Humira Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Humira Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Humira Sales 2019-2024 (K Units)
Figure 30. Americas Humira Revenue 2019-2024 ($ Millions)
Figure 31. APAC Humira Sales 2019-2024 (K Units)
Figure 32. APAC Humira Revenue 2019-2024 ($ Millions)
Figure 33. Europe Humira Sales 2019-2024 (K Units)
Figure 34. Europe Humira Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Humira Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Humira Revenue 2019-2024 ($ Millions)
Figure 37. Americas Humira Sales Market Share by Country in 2023
Figure 38. Americas Humira Revenue Market Share by Country in 2023
Figure 39. Americas Humira Sales Market Share by Type (2019-2024)
Figure 40. Americas Humira Sales Market Share by Application (2019-2024)
Figure 41. United States Humira Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Humira Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Humira Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Humira Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Humira Sales Market Share by Region in 2023
Figure 46. APAC Humira Revenue Market Share by Regions in 2023
Figure 47. APAC Humira Sales Market Share by Type (2019-2024)
Figure 48. APAC Humira Sales Market Share by Application (2019-2024)
Figure 49. China Humira Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Humira Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Humira Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Humira Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Humira Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Humira Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Humira Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Humira Sales Market Share by Country in 2023
Figure 57. Europe Humira Revenue Market Share by Country in 2023
Figure 58. Europe Humira Sales Market Share by Type (2019-2024)
Figure 59. Europe Humira Sales Market Share by Application (2019-2024)
Figure 60. Germany Humira Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Humira Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Humira Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Humira Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Humira Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Humira Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Humira Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Humira Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Humira Sales Market Share by Application (2019-2024)
Figure 69. Egypt Humira Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Humira Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Humira Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Humira Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Humira Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Humira in 2023
Figure 75. Manufacturing Process Analysis of Humira
Figure 76. Industry Chain Structure of Humira
Figure 77. Channels of Distribution
Figure 78. Global Humira Sales Market Forecast by Region (2025-2030)
Figure 79. Global Humira Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Humira Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Humira Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Humira Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Humira Revenue Market Share Forecast by Application (2025-2030)
